Campbell Neurosciences Spin Off of Therapeutic Solutions Reports Synergistic Reduction of Schizophrenia in Animal Models using Low Dose Naltrexone and T Regulatory Cell Stimulation

Katie, LDN, Fibromyalgia, pain, fatigue and brain fog (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Efficacy and safety of low-dose naltrexone in painful diabetic neuropathy: A randomized, double-blind, active-control, crossover clinical trial

J Diabetes
20 May 2021
https://pubmed.ncbi.nlm.nih.gov/34014028/

Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients

Hum Psychopharmacol
24 May 2021
https://pubmed.ncbi.nlm.nih.gov/34029405/

Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and Beta-Endorphin

eNeuro
24 May 2021
https://www.eneuro.org/content/early/2021/05/21/ENEURO.0087-21.2021

AgelessRx Launches Pilot Post-COVID Clinical Trial Using LDN and NAD

GetNews
25 May 2021
https://www.digitaljournal.com/pr/agelessrx-launches-pilot-post-covid-clinical-trial-using-ldn-and-nad

Low-Dose Naltrexone for Treating MS Symptoms

Verywell Health
05 January 2020
https://www.verywellhealth.com/naltrexone-for-ms-2440888

Pharmacist Kent MacLeod at the LDN Book Event 2020 (Low dose naltrexone) from LDN Research Trust on Vimeo.

Kent MacLeod, RPh., B.Sc., Owner & CEO of NutriChem Compounding Pharmacy & Clinic

Low-dose Naltrexone (LDN) & The Gut Microbiome

Nutrichem's LDN Book Events with Linda Elsegood (Low dose naltrexone) from LDN Research Trust on Vimeo.

The LDN Book Volume 2 & The Goals of the LDN Research Trust

The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia

Int J Pharm Compd
June 2018
https://pubmed.ncbi.nlm.nih.gov/29878893/